Skip to main content
Top
Published in: Acta Diabetologica 1/2015

01-02-2015 | Original Article

Body mass index and retinopathy in Asian populations with diabetes mellitus

Authors: David Rooney, Weng Kit Lye, Gavin Tan, Ecosse L. Lamoureux, Mohammad Kamran Ikram, Ching-Yu Cheng, Neelam Kumari, Ying Feng Zheng, Paul Mitchell, Jie Jin Wang, Tien Y. Wong, Charumathi Sabanayagam

Published in: Acta Diabetologica | Issue 1/2015

Login to get access

Abstract

Body mass index (BMI) is an established risk factor for diabetes. However, the association between BMI and diabetic retinopathy (DR) has been inconclusive. We aimed to assess the association between BMI and DR in a large population-based sample of multi-ethnic Asian adults in Singapore. We examined 2,278 adults aged ≥40 years with diabetes who participated in three population-based studies conducted from 2004 to 2011: the Singapore Malay Eye Study, the Singapore Indian Eye Study, and the Singapore Chinese Eye Study. Retinal photographs taken from both eyes were graded for any and vision-threatening (VTDR) using the modified Airlie House Classification. BMI (kg/m2) was categorized into normal/underweight (<25), overweight (25–29.9), and obese (≥30). The prevalence rates of any and VTDR in the study population were 35.1 % and 9.1 %, respectively. The prevalence of any and VTDR decreased with increasing categories of BMI (P trend <0.001 and 0.005). In multivariable models adjusted for potential confounders, compared to those with normal weight, the odds ratio (95 % confidence interval) of any DR was 0.71 (0.57–0.88) for overweight and 0.70 (0.53–0.92) for obese. Corresponding estimates for VTDR were 0.84 (0.59–1.21) for overweight and 0.58 (0.35–0.94) for obese. The inverse association between BMI and any DR was consistently present when BMI was analyzed as a continuous variable and in analyses stratified by ethnicity and age. In a population-based sample of multi-ethnic Asian adults, BMI levels were inversely associated with any DR and VTDR.
Literature
1.
go back to reference Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179–183PubMedCrossRef Klein BE (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179–183PubMedCrossRef
3.
go back to reference Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14PubMedCrossRef Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14PubMedCrossRef
5.
go back to reference Ruta LM, Magliano DJ, LeMesurier R, Taylor HR, Zimmet PZ, Shaw JE (2013) Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries. Diabet Med 30:387–398PubMedCrossRef Ruta LM, Magliano DJ, LeMesurier R, Taylor HR, Zimmet PZ, Shaw JE (2013) Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries. Diabet Med 30:387–398PubMedCrossRef
6.
go back to reference Ginter E, Simko V (2012) Global prevalence and future of diabetes mellitus. In: Ahmad S (ed) Diabetes: an old disease, a new insight. Springer, New York, pp 35–41 Ginter E, Simko V (2012) Global prevalence and future of diabetes mellitus. In: Ahmad S (ed) Diabetes: an old disease, a new insight. Springer, New York, pp 35–41
7.
go back to reference WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef
8.
go back to reference Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M (2009) Rationale for redefining obesity in Asians. Ann Acad Med Singapore 38:66–74PubMed Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M (2009) Rationale for redefining obesity in Asians. Ann Acad Med Singapore 38:66–74PubMed
9.
go back to reference Dirani M, Xie J, Fenwick E et al (2011) Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 52:74416–74421CrossRef Dirani M, Xie J, Fenwick E et al (2011) Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci 52:74416–74421CrossRef
10.
go back to reference VanLeiden HA, Dekker JM, Moll AC et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 25:1320–1323CrossRef VanLeiden HA, Dekker JM, Moll AC et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 25:1320–1323CrossRef
11.
go back to reference Ozmen B, Boyvada S (2003) The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy. J Diabetes Complicat 17:128–134PubMedCrossRef Ozmen B, Boyvada S (2003) The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy. J Diabetes Complicat 17:128–134PubMedCrossRef
12.
go back to reference Ballard DJ, Melton LJ 3rd, Dwyer MS et al (1986) Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9:334–342PubMedCrossRef Ballard DJ, Melton LJ 3rd, Dwyer MS et al (1986) Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9:334–342PubMedCrossRef
13.
go back to reference Zhang L, Krzentowski G, Albert A, Lefebvre PJ (2001) Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24:1275–1279PubMedCrossRef Zhang L, Krzentowski G, Albert A, Lefebvre PJ (2001) Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24:1275–1279PubMedCrossRef
14.
go back to reference Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMedCrossRef Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMedCrossRef
15.
go back to reference Klein R, Klein BE, Moss SE (1997) Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 157:650–656PubMedCrossRef Klein R, Klein BE, Moss SE (1997) Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 157:650–656PubMedCrossRef
16.
go back to reference Chaturvedi N, Fuller JH (1995) Mortality risk by body weight and weight change in people with NIDDM: the WHO multinational study of vascular disease in diabetes. Diabetes Care 18:766–774PubMedCrossRef Chaturvedi N, Fuller JH (1995) Mortality risk by body weight and weight change in people with NIDDM: the WHO multinational study of vascular disease in diabetes. Diabetes Care 18:766–774PubMedCrossRef
17.
go back to reference Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T (2010) Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol 47:209–215PubMedCrossRef Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T (2010) Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol 47:209–215PubMedCrossRef
18.
go back to reference Lim LS, Tai ES, Mitchell P et al (2010) C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci 51:4458–4463PubMedCrossRef Lim LS, Tai ES, Mitchell P et al (2010) C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci 51:4458–4463PubMedCrossRef
19.
go back to reference Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ (1986) Prevalence of diabetic complications in relation to risk factors. Diabetes 35:1332–1339PubMedCrossRef Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ (1986) Prevalence of diabetic complications in relation to risk factors. Diabetes 35:1332–1339PubMedCrossRef
20.
go back to reference Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140PubMedCrossRef Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140PubMedCrossRef
22.
go back to reference Lavanya R, Jeganathan VS, Zheng Y et al (2009) Methodology of the Singapore Indian Chinese Cohort (SICC) eye study: quantifying ethnic variations in the epidemiology of eye diseases in Asians. Ophthalmic Epidemiol 16:325–336PubMedCrossRef Lavanya R, Jeganathan VS, Zheng Y et al (2009) Methodology of the Singapore Indian Chinese Cohort (SICC) eye study: quantifying ethnic variations in the epidemiology of eye diseases in Asians. Ophthalmic Epidemiol 16:325–336PubMedCrossRef
23.
go back to reference Foong AWP, Saw SM, Loo JL et al (2007) Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay eye study (SiMES). Ophthalmic Epidemiol 14:25–35PubMedCrossRef Foong AWP, Saw SM, Loo JL et al (2007) Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay eye study (SiMES). Ophthalmic Epidemiol 14:25–35PubMedCrossRef
25.
go back to reference Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806CrossRef Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98:786–806CrossRef
26.
go back to reference Wong TY, Cheung N, Tay WT et al (2008) Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 115:1869–1875PubMedCrossRef Wong TY, Cheung N, Tay WT et al (2008) Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 115:1869–1875PubMedCrossRef
27.
go back to reference World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1–452 World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1–452
28.
go back to reference American Diabetes Association (2012) Standards of medical care in diabetes—2012. Diabetes Care 35:S11–S63CrossRef American Diabetes Association (2012) Standards of medical care in diabetes—2012. Diabetes Care 35:S11–S63CrossRef
29.
go back to reference Tapp RJ, Shaw JE, Harper CA et al (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737PubMedCrossRef Tapp RJ, Shaw JE, Harper CA et al (2003) The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:1731–1737PubMedCrossRef
30.
go back to reference VanLeiden HA, Dekker JM, Moll AC et al (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn Study. Arch Ophthalmol 121:245–251CrossRef VanLeiden HA, Dekker JM, Moll AC et al (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn Study. Arch Ophthalmol 121:245–251CrossRef
31.
go back to reference Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ (2007) Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye 21:465–471PubMed Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ (2007) Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye 21:465–471PubMed
33.
go back to reference Wong TY, Duncan BB, Golden SH et al (2004) Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk in Communities Study. Invest Ophthalmol Vis Sci 45:2949–2954PubMedCrossRef Wong TY, Duncan BB, Golden SH et al (2004) Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk in Communities Study. Invest Ophthalmol Vis Sci 45:2949–2954PubMedCrossRef
34.
go back to reference Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T (2009) Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med 55:92–96PubMedCrossRef Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T (2009) Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med 55:92–96PubMedCrossRef
35.
go back to reference Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V (2005) Prevalence of diabetic retinopathy in Urban India: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study, 1. Invest Ophthalmol Vis Sci 46:2328–2333CrossRef Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V (2005) Prevalence of diabetic retinopathy in Urban India: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study, 1. Invest Ophthalmol Vis Sci 46:2328–2333CrossRef
36.
go back to reference Xu J, Wei WB, Yuan MX et al (2012) Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina 32:322–329PubMedCrossRef Xu J, Wei WB, Yuan MX et al (2012) Prevalence and risk factors for diabetic retinopathy: the Beijing Communities Diabetes Study 6. Retina 32:322–329PubMedCrossRef
37.
go back to reference Pang C, Jia L, Jiang S et al (2012) Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes Metab Res Rev 28:276–283PubMedCrossRef Pang C, Jia L, Jiang S et al (2012) Determination of diabetic retinopathy prevalence and associated risk factors in Chinese diabetic and pre-diabetic subjects: Shanghai diabetic complications study. Diabetes Metab Res Rev 28:276–283PubMedCrossRef
38.
go back to reference Thomas G, Khunti K, Molokhia M et al (2014) Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab 16:317–325PubMedCrossRef Thomas G, Khunti K, Molokhia M et al (2014) Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease. Diabetes Obes Metab 16:317–325PubMedCrossRef
39.
go back to reference Carnethon MR, DeChavez PJ, Biggs ML et al (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308:581–590PubMedCentralPubMed Carnethon MR, DeChavez PJ, Biggs ML et al (2012) Association of weight status with mortality in adults with incident diabetes. JAMA 308:581–590PubMedCentralPubMed
40.
go back to reference McEwen LN, Kim C, Karter AJ et al (2007) Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 30:1736–1741PubMedCrossRef McEwen LN, Kim C, Karter AJ et al (2007) Risk factors for mortality among patients with diabetes: the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 30:1736–1741PubMedCrossRef
41.
go back to reference Moss SE, Meuer SM, Klein R, Hubbard LD, Brothers RJ, Klein BE (1989) Are seven standard photographic fields necessary for classification of diabetic retinopathy? Invest Ophthalmol Vis Sci 30:823–828PubMed Moss SE, Meuer SM, Klein R, Hubbard LD, Brothers RJ, Klein BE (1989) Are seven standard photographic fields necessary for classification of diabetic retinopathy? Invest Ophthalmol Vis Sci 30:823–828PubMed
42.
go back to reference Scanlon PH, Malhotra R, Grenwood RH et al (2003) Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthalmol 87:1258–1263PubMedCentralPubMedCrossRef Scanlon PH, Malhotra R, Grenwood RH et al (2003) Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy. Br J Ophthalmol 87:1258–1263PubMedCentralPubMedCrossRef
Metadata
Title
Body mass index and retinopathy in Asian populations with diabetes mellitus
Authors
David Rooney
Weng Kit Lye
Gavin Tan
Ecosse L. Lamoureux
Mohammad Kamran Ikram
Ching-Yu Cheng
Neelam Kumari
Ying Feng Zheng
Paul Mitchell
Jie Jin Wang
Tien Y. Wong
Charumathi Sabanayagam
Publication date
01-02-2015
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2015
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0602-2

Other articles of this Issue 1/2015

Acta Diabetologica 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.